FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER THORACIC ENDOPROSTHESIS
MDR report key: 1812204
·
Received August 19, 2010
Report
- Report Number
- 2017233-2010-00373
- Event Type
- Injury
- Date Received
- August 19, 2010
- Date of Event
- August 12, 2010
- Report Date
- August 19, 2010
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P040043
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AL, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. RESULTS- THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. THE SAFETY AND EFFECTIVENESS OF THE GORE TAG THORACIC ENDOPROSTHESIS HAS NOT BEEN EVALUATED IN PATIENT POPULATIONS INCLUDING INTRAMURAL HEMATOMAS AND PENETRATING ULCERS.
Description of Event or Problem · 1
ON (B)(6) 2008, THIS PATIENT WAS IMPLANTED WITH GORE TAG THORACIC ENDOPROSTHESIS TO TREAT AN INTRAMURAL HEMATOMA. ON (B)(6) 2010, THIS PATIENT UNDERWENT A REINTERVENTION USING GORE TAG THORACIC ENDOPROSTHESIS TO TREAT PROGRESSION OF A PENETRATING ULCER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER THORACIC ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG326 | 05025384 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Hospitalization| R |